Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R F Cummings

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Therapy|November 13, 2023
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in EuropeRan Jin, Chidozie Nduka, Delphine Courmier, et al.
Genes and Immunity|August 25, 2006
Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibilityD C Jones, R S Edgar, T Ahmad, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Oral methotrexate in ulcerative colitisJ R F Cummings, K R Herrlinger, S P L Travis, et al.
Tissue Antigens|October 5, 2010
Association of caspase-9 and RUNX3 with inflammatory bowel diseaseC Guo, T Ahmad, J Beckly, et al.
Alimentary Pharmacology & Therapeutics|October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patientsN A Kennedy, R Kalla, B Warner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Therapy|November 13, 2023
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in EuropeRan Jin, Chidozie Nduka, Delphine Courmier, et al.
Genes and Immunity|August 25, 2006
Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibilityD C Jones, R S Edgar, T Ahmad, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Oral methotrexate in ulcerative colitisJ R F Cummings, K R Herrlinger, S P L Travis, et al.
Tissue Antigens|October 5, 2010
Association of caspase-9 and RUNX3 with inflammatory bowel diseaseC Guo, T Ahmad, J Beckly, et al.
Alimentary Pharmacology & Therapeutics|October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patientsN A Kennedy, R Kalla, B Warner, et al.
Pageof 1